Related Experiment Video
Updated: Mar 1, 2026

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.2K
Cytopenia first - hepatitis second: an unusual sequence in aplastic anemia
Ferras Alashkar1, Daniel Föhring1, Ulrich Dührsen1
1Department of Hematology West German Cancer Centre University Hospital Essen University of Duisburg-Essen Essen Germany.
Clinical Case Reports
|June 8, 2017
Summary
This is the first report of aplastic anemia preceding autoimmune hepatitis. Successful treatment with immunosuppression led to recovery from both conditions.
Area of Science:
- Hematology
- Hepatology
- Immunology
Background:
- Autoimmune hepatitis (AIH) and aplastic anemia (AA) are distinct immune-mediated disorders.
- The co-occurrence and sequential presentation of these conditions are rare.
- Understanding the immunological overlap may reveal shared pathogenic mechanisms.
Observation:
- A patient presented with aplastic anemia (AA) followed by autoantibody-negative autoimmune hepatitis (AIH).
- The patient did not exhibit typical autoantibodies associated with AIH.
- This sequential presentation is unprecedented in medical literature.
Findings:
- Both aplastic anemia and autoimmune hepatitis were successfully treated using a single immunosuppressive regimen.
- Hematopoietic reconstitution occurred in the context of aplastic anemia treatment.
- Remission of autoimmune hepatitis was achieved concurrently with hematologic recovery.
Implications:
- This case suggests a potential shared autoimmune etiology or susceptibility between AA and AIH.
- The findings highlight the efficacy of a unified immunosuppressive approach for both conditions.
- Further research into the immunological links between these disorders is warranted.
Related Concept Videos
Disorders of Leukocytes
2.1K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.1K
Immunodeficiency Diseases
2.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.7K
Disorders of Erythrocytes
2.5K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.5K
Hypersensitivity Reactions: Cytolytic Reactions
69
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
69
Bone Marrow Sampling and Transplants
1.8K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.8K

